Keywords: sanofi-synthelabo, merger, strong, cardio, cns, proposed, between
Sanofi-Synthelabo Merger Strong In Cardio, CNS
Article | 10 December 1998
The proposed merger between Sanofi and Synthelabo (see page 3 andMarketletter December 7) would create a new entity with a strong focus ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
